Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tradjenta (linagliptin) and Victoza (liraglutide) are both prescription medications used to treat Type 2 diabetes, but they work in different ways and have different forms of administration. Tradjenta is a DPP-4 inhibitor taken orally once a day, while Victoza is a GLP-1 agonist that you inject under the skin daily. Tradjenta helps your body produce more insulin and reduce sugar production by blocking the DPP-4 protein, whereas Victoza works by telling your body to release more insulin, stop sugar release, and slow down digestion. Tradjenta is generally well-tolerated with common side effects like runny nose and diarrhea, but it can cause severe joint pain and increases the risk of pancreatitis. Victoza, on the other hand, can cause nausea, vomiting, and diarrhea, and it carries a risk of thyroid cancer and pancreatitis. Additionally, Victoza can help with weight loss and lower the risk of heart-related problems in certain adults with Type 2 diabetes. While Tradjenta is only available as brand medication, Victoza is available as a lower-cost generic.
Tradjenta (linagliptin)
Victoza (liraglutide)
Tradjenta (linagliptin)
Victoza (liraglutide)
Summary of Tradjenta vs. Victoza
Summary for DDP-4 inhibitor
Prescription only
Tradjenta (linagliptin) is a prescription medication that's used along with a balanced diet and exercise to manage blood sugar levels in adults with Type 2 diabetes. It's a type of diabetes medication called a dipeptidyl peptidase-4 (DPP-4) inhibitor. The dose is 5 mg (1 tablet) that's taken by mouth once per day. Tradjenta (linagliptin) doesn't cause many side effects but can sometimes include runny nose, sneezing, and diarrhea. As of 2024, Tradjenta (linagliptin) is available as a brand-name medication only; there's no generic version yet.
Summary for GLP-1 agonist
Prescription only
Victoza (liraglutide) is a medication that's injected once a day. It helps lower blood sugar levels in people 10 years and older with Type 2 diabetes when used with a nutritious diet and regular exercise. It can also help lower the risk of heart-related problems in adults with Type 2 diabetes and heart disease. Victoza (liraglutide) belongs to the drug class called GLP-1 agonists. The medication comes as single-dose prefilled pens and is injected under the skin. It can cause side effects like nausea, vomiting, diarrhea, and constipation. Victoza (liraglutide) is available as both a brand-name and generic medication.